Cardiac Contractility Modulation Electrical Signals Normalize Expression of the Excitation-Contraction Coupling Proteins Presenillin-2 and Sorcin in Left Ventricular Myocardium of Dogs with Chronic Heart Failure

Hani N. Sabbah,Ramesh C. Gupta,Sudhish Mishra,Mengjun Wang,Alice Jiang,Benny Rousso,Yuval Mika,Daniel Burkhoff

DOI: https://doi.org/10.1016/j.cardfail.2007.06.431

IF: 6.592

2007-01-01

Journal of Cardiac Failure

Abstract:Background: In the normal heart, during membrane depolarization, presenillin-2 (PS2) activates the sarcoplasmic reticulum (SR) ryanodine Ca2+ release channel (RyR2) to release large amounts of Ca2+ from the SR. At the end of systole (high Ca2+), sorcin (SOR) interacts with RyR2 to stop the SR Ca2+ release. In heart failure (HF), the RyR2 is “leaky” causing continuous release of Ca2+ into the cytosol and leading to Ca2+ overload as well as to depletion of calcium from the SR a maladaptation deemed detrimental in HF. We previously showed that long-term therapy with non-excitatory cardiac contractility modulation (CCM) electrical signals delivered to the LV myocardium during the absolute refractory period, improves SR calcium cycling. In this study, we examined the effects of long-term (3 months) CCM therapy on the expression of PS2 and SOR in LV of dogs with HF. Methods: RNA was extracted and tissue homogenate was prepared from LV tissue of 7 CCM-treated HF dogs, 7 untreated-HF dogs, and 6 normal (NL) dogs. mRNA expression was measured with reverse transcriptase polymerase chain reaction (RT-PCR) and protein expression with Western blots and bands quantified in densitometric units (du). Results: Data are shown in the table. Compared to NL dogs, mRNA and protein expression of PS2 increased and that of SOR decreased significantly in untreated HF dogs. Long-term therapy with CCM tended to normalize mRNA and protein expression of both PS2 and SOR. Conclusions: Chronic HF is associated with up-regulation of PS2 and down-regulation of SOR. Disregulation of these excitation-contraction coupling proteins in HF may be a key mediator of the SR Ca2+ “leak”. Long-term CCM therapy corrects this disregulation in dogs with HF and, in doing so, restores proper SR calcium cycling that ultimately contributes to improved overall LV function.Tabled 1Expression of PS2 and SORmRNA Expression (du)Protein Expression (du)NLHF-UntreatedHF + CCMNLHF-UntreatedHF + CCMPS20.29 ± 0.020.58 ± 0.02∗0.35 ± 0.02†0.21 ± 0.020.55 ± 0.02∗0.25 ± 0.02†SOR0.52 ± 0.020.20 ± 0.02∗0.35 ± 0.02∗†0.71 ± 0.020.27 ± 0.01∗0.43 ± 0.01∗†∗ = p < 0.05 vs. NL; † = p < 0.05 vs. HF-Untreated. Open table in a new tab ∗ = p < 0.05 vs. NL; † = p < 0.05 vs. HF-Untreated.